These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 12764406

  • 1. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG, Marbury TC, Robinson TD.
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M, Brommer P, Haag U, Miele C.
    Clin Drug Investig; 2009 Jun; 29(1):11-25. PubMed ID: 19067471
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
    Smith DH, Dubiel R, Jones M.
    Am J Cardiovasc Drugs; 2005 Jun; 5(1):41-50. PubMed ID: 15631537
    [Abstract] [Full Text] [Related]

  • 9. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
    Oparil S, Lee J, Karki S, Melino M.
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
    [Abstract] [Full Text] [Related]

  • 10. Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
    Neutel JM, Smith DH, Silfani TN, Lee Y, Weber MA.
    J Hum Hypertens; 2006 Apr; 20(4):255-62. PubMed ID: 16397514
    [Abstract] [Full Text] [Related]

  • 11. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A, Boivin JM, Bernaud C, Fay R, Zannad F, CIC General Practitioners Investigators' Group.
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [Abstract] [Full Text] [Related]

  • 12. Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies.
    Omboni S, Malacco E, Mallion JM, Volpe M, Zanchetti A, Study Group.
    J Hypertens; 2012 Jul; 30(7):1468-77. PubMed ID: 22573127
    [Abstract] [Full Text] [Related]

  • 13. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 14. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Barrios V, Brommer P, Haag U, Calderón A, Escobar C.
    Clin Drug Investig; 2009 May; 29(7):427-439. PubMed ID: 19499960
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone.
    Bilo G, Koch W, Hoshide S, Parati G.
    Hypertens Res; 2014 Sep; 37(9):836-44. PubMed ID: 24942766
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.
    Malacco E, Omboni S, Mallion JM, Volpe M, ESPORT Study Group.
    High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):213-22. PubMed ID: 23430666
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA, Shojaee A, Maa JF, Neutel JM.
    Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
    [Abstract] [Full Text] [Related]

  • 18. Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
    Kereiakes DJ, Maa JF, Shojaee A, Dubiel R.
    Am J Cardiovasc Drugs; 2010 Nov; 10(4):239-46. PubMed ID: 20653330
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J, Shojaee A, Maa JF.
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [Abstract] [Full Text] [Related]

  • 20. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM, Heagerty A, Laeis P.
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.